// App-Quantinova.ai

: Clinical and Biological Characteristics and Outcomes of Therapy-Related Acute Lymphoblastic Leukemia (t-ALL) Following Multiple Myeloma Are Distinct in Comparison to t-ALL Following Other Cancers

Researchers

Presenter

  • Josephine Anne Lucero

Principal Investigators

  • Brayan Merchan

  • Osamah Jamal S. Jarallah

  • Aniket Bankar

  • Steven M. Chan

  • Marta B. Davidson

  • Vikas Gupta

  • Dawn Maze

  • Mark D. Minden

  • Guillaume Richard-Carpentier

  • Aaron D. Schimmer

  • Andre C. Schuh

  • Karen Yee

  • Hassan Sibai

Medical Centers

  • Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada

  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

  • Division of Hematology, Department of Medicine, University of Toronto, Toronto, Canada

  • Division of Medical Oncology and Hematology, University Health Network, Toronto, Canada

  • Hematology Department, Hospital del Mar, Barcelona, Spain

Locations

  • Canada

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Multiple Myeloma

  • Solid malignancies

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Lactate dehydrogenase

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved